Heather Behanna Recent News
Wedbush Answers 'So, Now What?' For Novavax Shareholders
Need For New Drug Trial Increases Long-Term Risk For PTC Therapeutics, Says Wedbush
Wedbush Bullish On Sarepta's Eteplirsen Data
Achaogen Shares Upgraded To Outperform By Wedbush Following Optimistic Survey
Wedbush Upgrades Sarepta To Outperform As 'FDA Comes Up With Option C'
Wedbush Initiates Coverage On Cubist Pharmaceuticals
UPDATE: Wedbush Initiates Coverage On Tetraphase Pharmaceuticals On Room To Grow
UPDATE: Wedbush Initiates Coverage On Achaogen On High Clinical Risk
UPDATE: Wedbush Assumes Coverage On Noravax, Inc. As Stock Gears Up For Catalyst-Rich 2015
UPDATE: Wedbush Securities Initiates Coverage On Mirati Therapeutics, Inc. As Key Data Is Around The Corner